Research
Lantheus (LNTH) Stock Analysis & Research
- Latest rating
- Hold
- Latest report
- Aug 18, 2026
- Reports
- 1
- Sector
- Healthcare
Lantheus (LNTH) develops and commercializes radiopharmaceutical diagnostics and related products, with PYLARIFY as its core commercial engine alongside precision diagnostics and newer pipeline assets. Revenue comes from imaging agents, strategic partnerships, and other product sales.



